Walmart cuts prices | Vertex spends $10B | Rare earth worries grow

Monday was a good day for almost everything except Samsung. The Dow closed above 53,000 for the first time. The Nasdaq gained over 1 percent. Chips rebounded with Western Digital (WDC) and AMD (AMD) both jumping sharply. Dell (DELL) got a Trump shoutout at the White House and jumped 4 percent.

Samsung reported a record profit overnight. Its shares fell nearly 7 percent in Seoul anyway. South Korea's Kospi dropped sharply. SpaceX (SPCX) slipped slightly ahead of its Nasdaq-100 entrance. Brent climbed back toward $73 after Iran's Revolutionary Guard fired at two commercial ships near the Strait of Hormuz overnight. WTI held near $69.

Investor Signal

The Dow record and chip rebound signal broadening market strength. But Samsung's selloff on a record beat is a warning. Markets priced memory perfection already. The SK Hynix ADR starts trading Friday and faces the same test. FOMC minutes drop Wednesday. Both events will say more about where this goes than Monday's bounce did.

Most people think it's about search. It's not. It's about data.

Google collects 20X more of it than Apple — fueling an ad revenue engine that generates $250 billion annually. In the AI era, that data is more valuable than ever.

That's why investors are watching Mode Mobile.

While Big Tech profits from your clicks, searches, and behavior — Mode built a platform that lets users participate in the value they create. Its EarnOS platform rewards everyday smartphone activity and has already reached:

As AI makes user data increasingly valuable, Mode's opportunity keeps growing — and they've already locked in their Nasdaq ticker $MODE.

Pre-IPO shares are still available at just $0.52, with up to 20% bonus shares.

Get all the details here

Disclaimer:  Please read the offering circular and related risks at invest.modemobile.com. This is a paid advertisement for Mode Mobile’s Regulation A+ Offering. Mode Mobile recently received their ticker reservation with Nasdaq ($MODE), indicating an intent to IPO in the next 24 months. An intent to IPO is no guarantee that an actual IPO will occur. The Deloitte rankings are based on submitted applications and public company database research, with winners selected based on their fiscal-year revenue growth percentage over a three-year period.

Samsung Electronics reported Q2 preliminary operating income of roughly $58 billion. Beat expectations by 6 percent. Revenue more than doubled. Third consecutive record quarter. Shares still fell nearly 7 percent.

The selloff spread globally overnight. Micron (MU) dropped 6 percent in premarket. ASML (ASML) and Lam Research (LRCX) fell around 5 percent. The Kospi index dropped nearly 5 percent. A single Samsung reaction reset the entire memory sector.

The market wasn't surprised. It was already priced in. Samsung has been up over 150 percent this year. SK Hynix is up closer to 250 percent. The market already knew memory was printing money.

There's a new risk on the table too. Analysts flagged that 75 to 80 percent operating margins for the memory sector may draw regulatory scrutiny. That's the word "profiteering" entering the institutional conversation. That changes the risk profile even if the underlying demand is real.

What the Selloff Signals

The SK Hynix Test

If SK Hynix's ADR prices at the high end of its range Friday despite Samsung's reaction, the market is differentiating between pure-play AI memory and diversified conglomerates. A discount on SK Hynix confirms the selloff was broader than Samsung-specific.

Alibaba (BABA) banned employee use of Anthropic AI tools starting July 10. The reason given: back-door security risks. Claude Code landed on Alibaba's high-risk software list. Employees must switch to Alibaba's own Qoder assistant instead.

This follows Anthropic accusing Alibaba of "the largest known distillation attack" to date. Distillation is when a company trains its own AI model on outputs from a competitor's model. Anthropic says Alibaba did this at industrial scale to replicate Claude's capabilities.

Both sides have now formalized the break. Anthropic banned Chinese companies from using its models. Alibaba responded by banning Claude from its employees. The workarounds are getting closed too. Ant Group was accessing Claude through a Singapore entity. ByteDance was reimbursing engineers for VPN subscriptions. Both loopholes are being shut down.

The IPO Implication

For Anthropic's fall IPO, this is a two-sided story. Chinese companies tried to steal their capabilities. That's a validation. But it also means a significant global market is now effectively closed. Both facts need to appear in the S-1.

When a small group of private companies — not the Fed — will perform a major mint of a new kind of money.

And those who act before this new system fully kicks in could see gains as high as 40X by 2032. 

But those who fail to prepare will be blindsided by this sea change to the U.S. dollar.

Go here now for the details — before the September 8th mint hits the market.

Walmart (WMT) announced price cuts across thousands of products Monday. Ground beef down around 12 to 15 percent. Cherries halved. A 24-pack of Coca-Cola (KO) cut by a third. Trump called Walmart "absolute Patriots" on Truth Social and encouraged other retailers to follow.

Walmart shares actually slipped yesterday on the news. That's the seventh losing session in the last eight. Investors aren't celebrating the price cuts. Margin compression from tariff pass-through is the concern.

The political dynamic is more interesting than the pricing. Walmart is explicitly trading policy alignment for scale advantages. Lower tariffs and lower gas prices benefit Walmart more than any competitor. The Trump praise is the return on that investment.

The Competitor Problem

Kroger (KR), Target (TGT), and Costco (COST) now face pressure to match Walmart's cuts. They don't have Walmart's scale advantage on tariff pass-through. Matching the cuts means absorbing the margin hit directly. Not matching means losing price-sensitive customers to Walmart.

Vertex Pharmaceuticals (VRTX) announced a $10 billion deal for Crinetics (CRNX). The $85 per share price represents a 102 percent premium to Crinetics' close. Crinetics shares nearly doubled in extended trading. Vertex shares fell 2 percent.

Vertex has built its entire business on cystic fibrosis drugs. That franchise has been extraordinarily profitable. But concentration risk is real as biosimilar competition builds. The Crinetics acquisition adds endocrinology as a fifth treatment vertical alongside CF, hematology, pain, and renal.

The specific assets are strong. Palsonify is already FDA-approved for a rare hormonal disorder. A second drug in late-stage trials targets another rare condition with limited treatment options. Combined peak annual sales could reach $5 billion.

The Dealmaking Signal

Pharma M&A is accelerating across the board. Deep cash reserves, attractive biotech valuations, and patent cliff pressure are all converging. Any pharma company with CF-level concentration risk is now being pushed by investors to diversify before it's forced to.

When it was put inside U.S. tanks, they moved almost silently and produced no smoke. Now, Elon Musk is using this strange technology to jump ahead in the AI race - and possibly change the course of history. Click here to see how this could ignite a $10 trillion boom for the stocks involved.

Corporate Japan is getting increasingly vocal about rare earth supply. TSE filings mentioning rare earths doubled since May. More than two-thirds of companies filing said export controls were affecting their business negatively.

China controls most of the world's rare earth production. Beijing effectively cut off shipments after Japan's prime minister made comments about defending Taiwan. No terbium or dysprosium oxide has shipped to Japan from China for months. These materials go into motors, magnets, and increasingly AI supply chains.

Mizuho Research estimates the import halt could cut Japan's GDP by nearly 1 percent. That's a significant number for an economy already dealing with yen weakness and slowing export growth.

The Decoupling Timeline

Japan is pursuing stockpiling, G7 coordination, deep-sea mining projects, and recycling programs as alternatives. None of those solutions are fast. The structural dependency on Chinese rare earths is a multi-year problem with no near-term fix.

The AI Supply Chain Risk

Rare earths aren't just legacy industrial materials. They're in the motors, sensors, and magnets that AI hardware and robotics depend on. Companies like Citizen Watch and Omron are already flagging supply chain exposure. Q3 earnings will show how widespread the impact actually is.

The memory boom is fully priced in and regulators are starting to notice the margins. Alibaba and Anthropic formalized their corporate break. Walmart cut prices with explicit White House backing. Vertex paid a 102 percent premium to escape CF concentration. And Japan's rare earth warnings are getting louder as China keeps the spigot closed.

FOMC minutes drop Wednesday. The record highs and the structural cracks are both real right now.